Small noncoding RNAs regulate a variety of cellular processes, including genomic imprinting, chromatin remodeling, replication, transcription, and translation. Here, we report small replication-regulating RNAs (srRNAs) that specifically inhibit DNA replication of the human BK polyomavirus (BKV) in vitro and in vivo. srRNAs from FM3A murine mammary tumor cells were enriched by DNA replication assay-guided fractionation and hybridization to the BKV noncoding control region (NCCR) and synthesized as cDNAs. Selective mutagenesis of the cDNA sequences and their putative targets suggests that the inhibition of BKV DNA replication is mediated by srRNAs binding to the viral NCCR, hindering early steps in the initiation of DNA replication. Ectopic expression of srRNAs in human cells inhibited BKV DNA replication in vivo. Additional srRNAs were designed and synthesized that specifically inhibit simian virus 40 (SV40) DNA replication in vitro. These observations point to novel mechanisms for regulating DNA replication and suggest the design of synthetic agents for inhibiting replication of polyomaviruses and possibly other viruses.Small noncoding RNAs (ncRNAs) have important roles in eukaryotic gene expression determining developmental processes and growth and differentiation (reviewed in references 1, 8, 20, 27, 30, and 49). In addition, certain ncRNAs (e.g., Y-RNAs) are required for chromosomal DNA replication and proliferation of mammalian cells (5, 23); however, the mechanisms by which these act are not yet understood. Roles for ncRNAs in regulating viral infections of mammalian cells were uncovered with the discovery of virus-and host-encoded RNAs controlling viral gene expression (reviewed in references 10 and 41) and with the recognition that recruitment of the cellular origin recognition complex (ORC) to the viral origin of replication (OriP) by Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) and initiation of EBV DNA replication are RNA dependent (38).BK virus (BKV) infects nearly the entire human population but generally is innocuous unless viral replication is activated following kidney transplantation and immune suppression, when it may cause polyomavirus-associated nephropathy (PVAN) and allograft loss (14,19). Polyomavirus DNA replication in vitro and in vivo requires one viral protein, the large T antigen (TAg), with other factors supplied by the host cell (25, 28). Polyomavirus DNA replication initiates with TAg binding at the viral origin of replication (39, 44) and recruitment of host factors such as replication protein A (RPA), DNA polymerase ␣-primase (Pol-primase), and topoisomerase I (2, 45), followed by Pol-primase catalyzed de novo synthesis of nascent primers for DNA replication. Early initiation products, the nascent DNA primers, are then extended by DNA polymerase ␦ and proliferating cell nuclear antigen (PCNA) and the loading factor replication factor C on the leading and lagging strands (37,54). Although the DNA replication machineries are conserved between primates and rodents, BKV does not...